Retrospective Treatment Pattern Survey for the Patients With Hypertension and Stroke (SAPPHIRE)

This study has been completed.
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00681707
First received: May 19, 2008
Last updated: July 8, 2009
Last verified: July 2009

May 19, 2008
July 8, 2009
May 2008
Not Provided
Attainment rate to the target blood pressure [ Time Frame: After collecting all Patient Record Form. ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00681707 on ClinicalTrials.gov Archive Site
  • Dropout rate will be estimated during the follow-up period after the hypertension treatment. Attainment to the target blood pressure will be investigated according to concomitant diseases. [ Time Frame: After collecting all Patient Record Form. ] [ Designated as safety issue: No ]
  • Change in DBP/SBP value during the follow-up period will be addressed. Change in the DBP/SBP value will be investigated according to the risk factors and concurrent disease. [ Time Frame: After collecting all Patient Record Form. ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Retrospective Treatment Pattern Survey for the Patients With Hypertension and Stroke
A Retrospective, Multi Centre, Non-Interventional, Observational Study to Investigate Treatment Pattern of Blood Pressure in the Post Stroke Patients With Hypertension.

This study will address the treatment rate and control rate of hypertension, treatment pattern and factors that affect BP control by examining retrospective medical records of hypertension patients recovering from stroke, among outpatients coming to the Neurology Department in 10 university hospitals nationwide.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample

Patient with history of stroke, receiving hypertension medication during at least 1 year.

Hypertension
Not Provided
1
Hypertension patients recovering from stroke
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
1000
July 2008
Not Provided

Inclusion Criteria:

  • Patients had been hospitalized as a acute stroke in 2006
  • Patient with history of stroke receiving hypertension medication during at least 1 year.

Exclusion Criteria:

  • Secondary hypertension patients
  • Patients not receiving hypertension medication
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Korea, Republic of
 
NCT00681707
NIS-CKR-DUM-2008/1
No
Joonwoo Bahn, AstraZeneca
AstraZeneca
Not Provided
Study Director: Joon Woo Bahn Astrazenca Korea medical dept.
AstraZeneca
July 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP